TRYP Therapeutics Inc C.TRYP

Healthcare

Tryp Therapeutics Inc. is a Canada-based clinical-stage biotechnology company. The Company is focused on developing psilocybin-related molecules, including TRP-8803, for the treatment of diseases with unmet medical needs through accelerated regulatory pathways. The Company’s lead development program, Psilocybin-For-Neuropsychiatric Disorders (PFN) program, is designed to treat neuropsychiatric disorders through the dosing of formulations of synthetic psilocybin. The primary indications for its PFN are in the areas of chronic pain, including fibromyalgia, phantom limb pain and complex regional pain syndrome, and eating disorders, including binge eating and hypothalamic obesity. The Company's product pipeline includes TRP-8802 and TRP-8803. TRP-8803 uses a formulation and route of administration to improve the patient experience.

CSE:TRYP - Post by User

TRYP Therapeutics Inc

<< Previous

Bullboard Posts

Next >>

Post by SkywalkerofLukeon Jul 26, 2021 6:22pm

185 Views

Post# 33608204

Video on $TRYP

Been bullish on $TRYP for a while now with the cannabis/psychedelics market starting to go mainstream, and now they're currently working towards getting their psilocybin treatment FDA approved. Found this great video that breaks down just how $TRYP plans to get it done.

Discusses

- $TRYP ‘s strategy to fast track FDA approval

- Similarities to GW Pharma’s success post FDA approval

- Government’s acceptance of psychedelics treatments

- $TRYP ‘s management team

- Etc.

Great way to get familiar with $TRYP or catch up on their current status.

MC is $36.48M.

https://www.youtube.com/watch?v=fEJOi4aSjkE

<< Previous

Bullboard Posts

Next >>